Corbion NV
AEX:CRBN
Intrinsic Value
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. [ Read More ]
The intrinsic value of one CRBN stock under the Base Case scenario is 35.43 EUR. Compared to the current market price of 22.02 EUR, Corbion NV is Undervalued by 38%.
Valuation Backtest
Corbion NV
Run backtest to discover the historical profit from buying and selling CRBN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Corbion NV
Current Assets | 579.7m |
Cash & Short-Term Investments | 70.2m |
Receivables | 246.6m |
Other Current Assets | 262.9m |
Non-Current Assets | 1.1B |
Long-Term Investments | 18.6m |
PP&E | 798.4m |
Intangibles | 156.4m |
Other Non-Current Assets | 133.7m |
Current Liabilities | 588.3m |
Accounts Payable | 104.3m |
Other Current Liabilities | 484m |
Non-Current Liabilities | 462.3m |
Long-Term Debt | 417m |
Other Non-Current Liabilities | 45.3m |
Earnings Waterfall
Corbion NV
Revenue
|
1.4B
EUR
|
Cost of Revenue
|
-1.1B
EUR
|
Gross Profit
|
373.9m
EUR
|
Operating Expenses
|
-224.3m
EUR
|
Operating Income
|
149.6m
EUR
|
Other Expenses
|
-76.7m
EUR
|
Net Income
|
72.9m
EUR
|
Free Cash Flow Analysis
Corbion NV
CRBN Profitability Score
Profitability Due Diligence
Corbion NV's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Corbion NV's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CRBN Solvency Score
Solvency Due Diligence
Corbion NV's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Corbion NV's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRBN Price Targets Summary
Corbion NV
According to Wall Street analysts, the average 1-year price target for CRBN is 25.05 EUR with a low forecast of 13.53 EUR and a high forecast of 31.5 EUR.
Shareholder Return
CRBN Price
Corbion NV
Average Annual Return | 9.63% |
Standard Deviation of Annual Returns | 40.07% |
Max Drawdown | -69% |
Market Capitalization | 1.3B EUR |
Shares Outstanding | 59 012 900 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. The company is headquartered in Amsterdam, Noord-Holland and currently employs 2,493 full-time employees. The firm's products include lactic acid derivatives, emulsifiers, functional enzyme blends, minerals and vitamins, among others. The company operates through two business lines: Ingredient Solutions, divided into business segments Food and Biochemicals, as well as Innovation Platforms. The Food segment develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals segment produces bio-based chemicals derived from renewable resources such as sugar or starch. The Innovation Platforms segment creates new biotechnology business platforms, such as the poly lactic acid (PLA) bioplastic or its algae ingredients business. The firm operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.
Contact
IPO
Employees
Officers
The intrinsic value of one CRBN stock under the Base Case scenario is 35.43 EUR.
Compared to the current market price of 22.02 EUR, Corbion NV is Undervalued by 38%.